Supplemental material
Open access
1,245
Views
5
CrossRef citations to date
0
Altmetric
Research Paper
Synthesis and preliminary structure-activity relationship study of 2-aryl-2H-pyrazolo[4,3-c]quinolin-3-ones as potential checkpoint kinase 1 (Chk1) inhibitors
Ivana MalvacioDepartment of Organic Chemistry, INFIQC, School of Chemical Sciences, National University of Cordoba, Cordoba, Argentina; ;Molecular Modeling Section (MMS), Dipartimento di Scienze Farmaceutiche, Università degli Studi di Padova, via Marzolo, Padova, Italy; View further author information
, Alberto CuzzolinMolecular Modeling Section (MMS), Dipartimento di Scienze Farmaceutiche, Università degli Studi di Padova, via Marzolo, Padova, Italy; View further author information
, Mattia SturleseMolecular Modeling Section (MMS), Dipartimento di Scienze Farmaceutiche, Università degli Studi di Padova, via Marzolo, Padova, Italy; http://orcid.org/0000-0003-3944-0313View further author information
, D. Mariano A. VeraDepartment of Chemistry, QUIAMM-INBIOTEC, School of Exact and Natural Sciences, National University of Mar del Plata, Mar del Plata, Buenos Aires, ArgentinaView further author information
, E. Laura MoyanoDepartment of Organic Chemistry, INFIQC, School of Chemical Sciences, National University of Cordoba, Cordoba, Argentina; Correspondence[email protected], [email protected]
View further author information
& View further author information
Stefano MoroMolecular Modeling Section (MMS), Dipartimento di Scienze Farmaceutiche, Università degli Studi di Padova, via Marzolo, Padova, Italy; Correspondence[email protected], [email protected]
View further author information
View further author information
Pages 171-183
|
Received 21 Sep 2017, Accepted 08 Nov 2017, Published online: 06 Dec 2017
Related Research Data
Microwave Assisted Synthesis of ethyl-quinolon-4-one-3-carboxylates and Hydrolysis to quinolon-4-one-3-carboxylic Acids
Source:
Bentham Science Publishers Ltd.
Langevin dynamics of peptides: The frictional dependence of isomerization rates of N‐acetylalanyl‐N′‐methylamide
Source:
Wiley
UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53
Source:
Oxford University Press (OUP)
A smooth particle mesh Ewald method
Source:
AIP Publishing
Structural evaluation of three 2-phenylpyrazolo[4,3-c]quinolin-3-one monohydrates
Source:
Elsevier BV
The antitumor activity of novel pyrazoloquinoline derivatives
Source:
Elsevier BV
2-Arylpyrazolo[4,3-c]quinolin-3-ones: novel agonist, partial agonist, and antagonist of benzodiazepines.
Source:
American Chemical Society (ACS)
A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations
Source:
Wiley
Will Targeting Chk1 Have a Role in the Future of Cancer Therapy
Source:
American Society of Clinical Oncology (ASCO)
Chk1 and Chk2 kinases in checkpoint control and cancer.
Source:
Elsevier BV
Deciphering the Complexity of Ligand–Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations
Source:
American Chemical Society (ACS)
Structure-Based Design of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding and Protein-Ligand Affinity.
Source:
American Chemical Society (ACS)
Discovery of a novel class of triazolones as checkpoint kinase inhibitors--hit to lead exploration.
Source:
Elsevier BV
A phase I dose-escalation study of SCH 900776, a selective inhibitor of checkpoint kinase 1 (CHK1), in combination with gemcitabine (Gem) in subjects with advanced solid tumors.
Source:
American Society of Clinical Oncology (ASCO)
Recent developments in the chemistry of pyrazolo[4,3-c]quinolines
Source:
Elsevier BV
Comparison of multiple Amber force fields and development of improved protein backbone parameters.
Source:
Wiley
Computational studies on the binding mechanism between triazolone inhibitors and Chk1 by molecular docking and molecular dynamics
Source:
Royal Society of Chemistry (RSC)
1,2‐Diaryl‐1‐ethanone and Pyrazolo[4,3‐c]quinoline‐4‐one as Novel Selective Cyclooxygenase‐2 Inhibitors
Source:
Wiley
Synthesis and preliminary structure-activity relationship study of 2-aryl-2H-pyrazolo[4,3-c]quinolin-3-ones as potential checkpoint kinase 1 (Chk1) inhibitors
Source:
Taylor & Francis
Identification of new checkpoint kinase-1 (Chk1) inhibitors by docking, 3D-QSAR, and pharmacophore-modeling methods
Source:
Canadian Science Publishing
Structural basis for Chk1 inhibition by UCN-01.
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors.
Source:
Elsevier BV
Protonate3D: Assignment of ionization states and hydrogen coordinates to macromolecular structures
Source:
Wiley
Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties
Source:
Elsevier BV
Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
Source:
Springer Nature
DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
Source:
American Association for Cancer Research (AACR)
Molecular dynamics with coupling to an external bath.
Source:
AIP Publishing
Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25
Source:
American Association for the Advancement of Science (AAAS)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.